MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Evaluating Inter-rater Variability in UPDRS Using IMU: A Comparison Between Beginner and Experienced Specialists

    TC. Fang, PS. Lu, YJ. Guo, JA. Huang, LW. Ko (Taichung, Taiwan)

    Objective: This study aims to determine whether an inertial measurement unit (IMU) can detect differences in the consistency of Movement Disorder Society-Unified Parkinson's Disease Rating…
  • 2025 International Congress

    Incidence and Associated Factors for Phenoconversion of Parkinson’s Disease in the Chinese Community Older Adults with LRRK2 G2385R and R1628P Variants

    J. Liu, T. Mi, Z. Gu, Y. Li, M. Cao, Z. Ren, H. Zhang, M. Chen, J. Chen, L. Ma, X. Xu, C. Han, L. Zhang, J. An, P. Chan (Beijing, China)

    Objective: To investigate the 10-year accumulated incidence and associated factors for phenoconversion of Parkinson’s disease (PD) in community older adults carrying LRRK2 G2385R or/and R1628P variants. Background: Previous…
  • 2025 International Congress

    The Cleveland Clinic-Virtual Home Environment (CC-VHE): A Reliable Way to Trigger Freezing of Gait in Parkinson’s disease

    A. Rosenfeldt, M. Miller Koop, A. Bazyk, V. Berki, S. Nagel, B. Walter, J. Liao, K. Baker, J. Alberts (Cleveland, USA)

    Objective: To describe the development, safety, and efficacy of the Cleveland Clinic-Virtual Home Environment (CC-VHE) in provoking freezing of gait (FOG) in Parkinson’s disease (PD).…
  • 2025 International Congress

    A personalized gait signature assay in Parkinson’s disease

    H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)

    Objective: To establish a personalized gait signature assay to inform on progression, phenotype and effects of intervention of gait abnormalities in PD. Background: Gait signatures…
  • 2025 International Congress

    Health Disparity in Rural Southern California

    A. Maleki, M. Tar, D. Tar (moreno valley, USA)

    Objective: To analyze the demographic and clinical characteristics of hispanic patients with Parkinson's disease in rural southern California Background: Parkinson’s disease (PD) is the second…
  • 2025 International Congress

    The Role of Knowledgeable Informants in the Early Detection of Parkinson’s Disease

    E. Trinh, K. Harrison, M. Korell, C. Meng, E. Brown, K. Comyns, X. Chen, M. Bock, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)

    Objective: To investigate the reporting of changes observed by Knowledgeable Informants (KIs) and people with Parkinson’s disease (PwPD) prior to a Parkinson’s disease (PD) diagnosis.…
  • 2025 International Congress

    Pesticide Exposure and Parkinson’s Disease Motor Subtype

    D. Thordarson, J. Bronstein, A. Keener, B. Ritz, K. Paul (Los Angeles, USA)

    Objective: The present study aims to investigate the link between Parkinson’s disease (PD) motor subtype and PD-relevant pesticide exposures. Background: PD is a neurodegenerative disorder…
  • 2025 International Congress

    Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

    M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

    Objective: To study and systematize the clinical characteristics of Parkinson's disease (PD) and their role in differential diagnosis with other parkinsonian syndromes. Background: Parkinson’s disease…
  • 2025 International Congress

    A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: The main purpose of this study was to assess how AI and ML methods integrate multiple biomarkers for diagnosing Parkinson’s Disease (PD) to improve…
  • 2025 International Congress

    Establishing a Timeline of Non-Motor and Motor Symptoms Progression in Parkinson’s Disease Using a Sub-Chronic MPTP Mouse Model

    M. Chopra, A. Sekar, R. Hussain, L. Diwakar (Bengaluru, India)

    Objective: Parkinson’s disease (PD) mouse model using 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was explored for pathological mechanisms driving non-motor symptoms (NMS). Aim was to map the behavioural changes…
  • « Previous Page
  • 1
  • …
  • 181
  • 182
  • 183
  • 184
  • 185
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley